These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 30121013)

  • 1. Hypoxic tumor therapy by hemoglobin-mediated drug delivery and reversal of hypoxia-induced chemoresistance.
    Yang J; Li W; Luo L; Jiang M; Zhu C; Qin B; Yin H; Yuan X; Yin X; Zhang J; Luo Z; Du Y; You J
    Biomaterials; 2018 Nov; 182():145-156. PubMed ID: 30121013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extremely Effective Chemoradiotherapy by Inducing Immunogenic Cell Death and Radio-Triggered Drug Release under Hypoxia Alleviation.
    Zhu C; Guo X; Luo L; Wu Z; Luo Z; Jiang M; Zhang J; Qin B; Shi Y; Lou Y; Qiu Y; You J
    ACS Appl Mater Interfaces; 2019 Dec; 11(50):46536-46547. PubMed ID: 31751119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential Intercellular Delivery Nanosystem for Enhancing ROS-Induced Antitumor Therapy.
    Wang B; Zhang H; An J; Zhang Y; Sun L; Jin Y; Shi J; Li M; Zhang H; Zhang Z
    Nano Lett; 2019 Jun; 19(6):3505-3518. PubMed ID: 31034238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fullerene (C60)-based tumor-targeting nanoparticles with "off-on" state for enhanced treatment of cancer.
    Shi J; Wang B; Wang L; Lu T; Fu Y; Zhang H; Zhang Z
    J Control Release; 2016 Aug; 235():245-258. PubMed ID: 27276066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced drug delivery using sonoactivatable liposomes with membrane-embedded porphyrins.
    Wang X; Yan F; Liu X; Wang P; Shao S; Sun Y; Sheng Z; Liu Q; Lovell JF; Zheng H
    J Control Release; 2018 Sep; 286():358-368. PubMed ID: 30075210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Implantable Depot That Can Generate Oxygen in Situ for Overcoming Hypoxia-Induced Resistance to Anticancer Drugs in Chemotherapy.
    Huang CC; Chia WT; Chung MF; Lin KJ; Hsiao CW; Jin C; Lim WH; Chen CC; Sung HW
    J Am Chem Soc; 2016 Apr; 138(16):5222-5. PubMed ID: 27075956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ROS-sensitive thioketal-linked polyphosphoester-doxorubicin conjugate for precise phototriggered locoregional chemotherapy.
    Pei P; Sun C; Tao W; Li J; Yang X; Wang J
    Biomaterials; 2019 Jan; 188():74-82. PubMed ID: 30336287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide-modification enhances the delivery and targeting of doxorubicin-loaded liposomes to somatostatin receptors expressing tumor in vitro and in vivo.
    Sun M; Wang Y; Shen J; Xiao Y; Su Z; Ping Q
    Nanotechnology; 2010 Nov; 21(47):475101. PubMed ID: 21030757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting Hypoxia and Chemotherapy-Induced Cancer Cell Metastasis under a Valid Therapeutic Effect by an Assistance of Biomimetic Oxygen Delivery.
    Jiang MS; Yin XY; Qin B; Xuan SY; Yuan XL; Yin H; Zhu C; Li X; Yang J; Du YZ; Luo LH; You J
    Mol Pharm; 2019 Nov; 16(11):4530-4541. PubMed ID: 31617723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-Delivery of Metformin Enhances the Antimultidrug Resistant Tumor Effect of Doxorubicin by Improving Hypoxic Tumor Microenvironment.
    Li Y; Luo J; Lin MT; Zhi P; Guo WW; Han M; You J; Gao JQ
    Mol Pharm; 2019 Jul; 16(7):2966-2979. PubMed ID: 31095914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a hypoxia-triggered and hypoxic radiosensitized liposome as a doxorubicin carrier to promote synergetic chemo-/radio-therapy for glioma.
    Liu H; Xie Y; Zhang Y; Cai Y; Li B; Mao H; Liu Y; Lu J; Zhang L; Yu R
    Biomaterials; 2017 Mar; 121():130-143. PubMed ID: 28088075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of antitumor effect of doxorubicin by its complexation with gamma-cyclodextrin in pegylated liposomes.
    Arima H; Hagiwara Y; Hirayama F; Uekama K
    J Drug Target; 2006 May; 14(4):225-32. PubMed ID: 16777681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo.
    Qiu M; Sun H; Meng F; Cheng R; Zhang J; Deng C; Zhong Z
    J Control Release; 2018 Feb; 272():107-113. PubMed ID: 29355618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
    Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bifunctional liposomes reduce the chemotherapy resistance of doxorubicin induced by reactive oxygen species.
    Xu L; Zhang Z; Ding Y; Wang L; Cheng Y; Meng L; Wu J; Yuan A; Hu Y; Zhu Y
    Biomater Sci; 2019 Nov; 7(11):4782-4789. PubMed ID: 31524211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes.
    Dicheva BM; ten Hagen TL; Seynhaeve AL; Amin M; Eggermont AM; Koning GA
    Pharm Res; 2015 Dec; 32(12):3862-76. PubMed ID: 26202516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting acute hypoxic cancer cells by doxorubicin-immunoliposomes directed by monoclonal antibodies specific to RON receptor tyrosine kinase.
    Guin S; Ma Q; Padhye S; Zhou YQ; Yao HP; Wang MH
    Cancer Chemother Pharmacol; 2011 May; 67(5):1073-83. PubMed ID: 20658288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo.
    Xiong XB; Huang Y; Lu WL; Zhang X; Zhang H; Nagai T; Zhang Q
    J Pharm Sci; 2005 Aug; 94(8):1782-93. PubMed ID: 15986461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular structural transformation regulated dynamic disordering of supramolecular vesicles as pH-responsive drug release systems.
    Liu Y; Gao FP; Zhang D; Fan YS; Chen XG; Wang H
    J Control Release; 2014 Jan; 173():140-7. PubMed ID: 24188958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-targeted hybrid protein oxygen carrier to simultaneously enhance hypoxia-dampened chemotherapy and photodynamic therapy at a single dose.
    Luo Z; Tian H; Liu L; Chen Z; Liang R; Chen Z; Wu Z; Ma A; Zheng M; Cai L
    Theranostics; 2018; 8(13):3584-3596. PubMed ID: 30026868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.